v
Search
Advanced

Publications > Journals > Most Viewed Articles

Results per page:
v
Original Article Open Access
Yan Ouyang, Yanjun Luo, Yuxin Zhan, Min Liu, Qi Li, Wenjing Li, Lianlian Qu, Suyun Li
Published online September 28, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 857
Neurosurgical Subspecialties. doi:10.14218/NSSS.2026.00013
Abstract
Therapeutic hypothermia (TH) is widely used as a neuroprotective strategy, but variability in bedside implementation may limit its optimal application. This study aimed to develop [...] Read more.

Therapeutic hypothermia (TH) is widely used as a neuroprotective strategy, but variability in bedside implementation may limit its optimal application. This study aimed to develop a standardized TH management protocol for patients with neurocritical illness and evaluate the clinical outcomes associated with its implementation.

An evidence-based TH protocol was developed through a two-round Delphi consensus process. A subsequent observational before-and-after study included 244 patients with neurocritical illness receiving TH. The historical control group (n = 120) received routine care, whereas the TH protocol group (n = 124) was managed according to the standardized protocol. No single primary endpoint was prespecified for the final comparative analysis. Outcomes were interpreted as exploratory and included temperature-management process indicators, individual TH-related complications requiring intervention, and neurological outcomes assessed using the Glasgow Outcome Scale.

Protocol implementation was associated with more favorable temperature-management process indicators, including earlier TH initiation, a shorter recorded time to target temperature, fewer unplanned treatment interruptions, a longer controlled rewarming phase, and greater adherence to rewarming criteria. In exploratory analyses, the TH protocol group had lower incidences of selected TH-related complications and more favorable Glasgow Outcome Scale outcomes at discharge than the historical control group.

Implementation of a consensus-derived TH management protocol was associated with more consistent temperature-management processes, fewer selected TH-related complications, and more favorable short-term neurological outcomes. These findings support prospective evaluation of protocolized TH management in larger multicenter cohorts.

Full article
Opinion Open Access
Kimia Kazemzadeh
Published online September 24, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 824
Neurosurgical Subspecialties. doi:10.14218/NSSS.2026.00017
Editorial Open Access
Lijun Hou
Published online September 28, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 777
Neurosurgical Subspecialties. doi:10.14218/NSSS.2026.00027
Original Article Open Access
Yuan Ding, Lihua Ren, Ruihua Shi
Published online October 30, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 762
Cancer Screening and Prevention. doi:10.14218/CSP.2026.00017
Abstract
N-acetyltransferase 10 (NAT10), a major RNA acetyltransferase mediating N4-acetylcytidine modification, has been implicated in cancer progression. We examined its cancer-type-specific [...] Read more.

N-acetyltransferase 10 (NAT10), a major RNA acetyltransferase mediating N4-acetylcytidine modification, has been implicated in cancer progression. We examined its cancer-type-specific associations with clinical outcomes, genomic features, and tumor immune characteristics.

We analyzed public TCGA and GTEx datasets using UCSC Xena and complementary resources, including GEPIA2, HPA, cBioPortal, TIMER2.0, STRING, LinkedOmics, and CancerSEA. Analyses included NAT10 expression, pathological stage, survival, genomic alterations, immune-cell infiltration, stemness, and molecular pathways. Exploratory immune-checkpoint-blockade (ICB) survival analyses used Kaplan–Meier Plotter cohorts receiving anti-PD-1 (n = 411), anti-PD-L1 (n = 459), or anti-CTLA-4 (n = 112).

NAT10 expression was elevated in multiple cancer types and was associated with adverse survival in selected malignancies. Higher NAT10 expression correlated positively with estimated myeloid-derived suppressor cell and cancer-associated fibroblast infiltration and negatively with several T-cell and natural killer-cell populations. NAT10-associated genes were enriched in RNA-processing pathways. In exploratory ICB cohorts, higher NAT10 expression was nominally associated with longer overall survival following anti-PD-1 therapy (hazard ratio (HR) = 0.68, 95% confidence interval (CI): 0.52–0.90) and anti-PD-L1 therapy (HR = 0.72, 95% CI: 0.56–0.92), but not anti-CTLA-4 therapy (HR = 0.66, 95% CI: 0.39–1.11).

NAT10 shows cancer-type-dependent prognostic, molecular, and immune associations. Its associations with survival after ICB are exploratory and require independent clinical and mechanistic validation.

Full article
Consensus Open Access
Peng Pan, Cheng-Long Wang, Sheng-Bing Zhao, Xiuli Zuo, Zhen-Dong Jin, Zhuan Liao, Yu Bai
Published online November 3, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 680
Cancer Screening and Prevention. doi:10.14218/CSP.2026.00022
Abstract
Colorectal diseases pose a serious threat to human health, and conventional endoscopy has limitations in lesion characterization. This consensus aims to clarify the indications, [...] Read more.

Colorectal diseases pose a serious threat to human health, and conventional endoscopy has limitations in lesion characterization. This consensus aims to clarify the indications, operational specifications, image interpretation criteria, and quality control requirements for probe-based confocal laser endomicroscopy (pCLE) in lower gastrointestinal diseases, particularly colorectal cancer, precancerous lesions and polyps, and inflammatory bowel disease (IBD). A systematic literature search covered PubMed, Embase, the Cochrane Library, CNKI, and Wanfang Database through August 2026. Evidence was graded using the Grading of Recommendations Assessment, Development and Evaluation system. Forty-eight experts participated in two rounds of discussion and online voting, with agreement ≥80% required for consensus. Eight recommendations were finalized: five strong and three weak. Strong recommendations address colorectal lesion differentiation, targeted biopsy, mucosal barrier assessment, ulcerative colitis mucosal healing and relapse prediction, and IBD-associated colorectal neoplasia surveillance. Weak recommendations address distal resection margin assessment during radical surgery for low rectal cancer, irritable bowel syndrome research, and adjunctive IBD diagnosis and differentiation. Evidence for endoscopic resection margin assessment remains insufficient, and pCLE is not recommended for routine diagnosis of irritable bowel syndrome. pCLE provides adjunctive microscopic information for colorectal lesion characterization, targeted biopsy, and IBD assessment and surveillance; in IBD diagnosis, it does not replace conventional endoscopic and histopathological evaluation. This consensus provides evidence-based guidance for standardized clinical application.

Full article
Original Article Open Access
Philips N. Okeagu, Godisgreat O. Okeke, Chidindu P. Anagwu, Joseph Atarere
Published online October 28, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 649
Cancer Screening and Prevention. doi:10.14218/CSP.2026.00016
Abstract
We compared logistic regression, random forest, and extreme gradient boosting (XGBoost) for classifying current colorectal cancer screening status among U.S. adults aged 45–75 years. We [...] Read more.

We compared logistic regression, random forest, and extreme gradient boosting (XGBoost) for classifying current colorectal cancer screening status among U.S. adults aged 45–75 years.

We analyzed 2024 Behavioral Risk Factor Surveillance System data for 227,647 adults aged 45–75 years with determinable screening status. Data were split into stratified training and held-out test sets before imputation. Missing predictors were handled with 20 multiply imputed datasets; imputation and preprocessing were fitted in training data and applied to held-out data. Model performance was assessed using five-fold cross-validation and the held-out test set.

In the test set, areas under the receiver operating characteristic curve were 0.771 for logistic regression, 0.778 for random forest, and 0.781 for XGBoost; corresponding areas under the precision-recall curve were 0.884, 0.888, and 0.890. Brier scores were 0.152, 0.153, and 0.149, respectively. At model-specific Youden thresholds, sensitivity ranged from 75.5% to 78.6% and specificity from 62.5% to 66.3%.

XGBoost has the highest discrimination and lowest Brier score, but differences among models are small. The models classify current screening status in this analytic cohort; external validation is needed before use in screening outreach.

Full article
Review Article Open Access
Nicolas Chardon, Frank Bidar, Paul Abraham, Didier Payen, Thomas Rimmelé
Published online September 28, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 643
Journal of Translational Critical Care Medicine. doi:10.14218/JTCCM.2026.00017
Abstract
Extensive burn injuries are associated with a profound systemic response, the severity of which increases with the extent of tissue damage. Beyond local destruction, extensive burns [...] Read more.

Extensive burn injuries are associated with a profound systemic response, the severity of which increases with the extent of tissue damage. Beyond local destruction, extensive burns induce a sustained immune-inflammatory disturbance that alters immune regulation and contributes to secondary organ failure and infectious complications. These mechanisms are major determinants of adverse outcomes in critically ill patients with burns. In this context, therapeutic strategies targeting immune dysregulation have gained increasing attention. Immunomodulatory approaches aim to limit excessive inflammatory signaling while maintaining effective host defense. Among extracorporeal blood purification techniques, hemoadsorption has emerged as a potential adjunctive therapy designed to reduce circulating inflammatory mediators, particularly cytokines, and to attenuate systemic inflammatory burden. Rather than providing another general overview of extracorporeal blood purification, this review focuses specifically on the cellular and mechanistic basis of burn-induced immune dysregulation and offers a stratified, critical appraisal of the experimental and clinical evidence for hemoadsorption in burns, together with current safety considerations and unresolved questions that should guide future research. Experimental studies and early clinical observations suggest that hemoadsorption may contribute to hemodynamic stabilization and modulation of inflammation in critically ill patients, including those with severe burns. However, clinical evidence in this specific population remains scarce, and its impact on patient-centered outcomes has not yet been established. Although available data suggest that this technique is generally well tolerated, the non-selective removal of circulating molecules underscores the need for careful patient selection and close monitoring. Future investigations should focus on defining the appropriate indications, optimal timing, and treatment duration of hemoadsorption for burn care. Comparative studies with other immunomodulatory strategies are required to clarify its role within the therapeutic armamentarium for burn-induced immune dysfunction.

Full article
Letter to the Editor Open Access
Eyad Gadour
Published online October 15, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 613
Journal of Translational Gastroenterology. doi:10.14218/JTG.2026.00035
Letter to the Editor Open Access
Hakim Rahmoune, Nada Boutrid, Hala Boutrid, Samir Iddir
Published online October 19, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 599
Exploratory Research and Hypothesis in Medicine. doi:10.14218/ERHM.2026.00044
Mini Review Open Access
Peng-Yu Zhao, Ming-Zhu Jin, Wei-Lin Jin
Published online September 29, 2026
[ Html ] [ PDF ] [ Google Scholar ] [ Cite ]  Views: 555
Oncology Advances. doi:10.14218/OnA.2026.00015
Abstract
Interactions among tumors, nerves, and immune cells influence cancer progression, but the mechanisms coordinating these compartments remain incompletely understood. Bioelectric [...] Read more.

Interactions among tumors, nerves, and immune cells influence cancer progression, but the mechanisms coordinating these compartments remain incompletely understood. Bioelectric signaling has been proposed as an additional coordinating layer, yet direct in vivo evidence for a tumor–nerve–immune electrical axis remains limited. In non-tumor models, RUSH3D-HR enables mesoscale in vivo imaging of dynamic cellular behaviors, including neutrophil swarming and migrasome dynamics, and has revealed reduced splenic neutrophil swarming following electroacupuncture at Zusanli (ST36). These observations provide dynamic cellular readouts and demonstrate an intervention-associated response; however, the platform does not directly measure membrane voltage, ionic currents, or electric fields, and these findings establish neither electrical coupling nor a specific neural circuit. In this mini review, we examine the proposed axis as a focused, falsifiable complement to broader cancer neuroscience. We distinguish direct observations from mechanistic hypotheses, consider established biochemical explanations involving neurotransmitters and inflammatory mediators, and discuss how context-dependent neural effects, supporting glial cells, opioids, and cancer-induced nerve injury may modify tumor–nerve–immune interactions. We then outline a staged experimental roadmap in tumor models, integrating RUSH3D-HR with voltage and ion reporters, extracellular electrophysiological recordings, and compartment-specific perturbations. This framework prioritizes temporal relationships, identification of candidate signal sources and responding compartments, and causal tests that discriminate electrical contributions from biochemical and systemic effects. Establishing reproducible links between electrical measurements, cellular behavior, and tumor outcomes will be essential for evaluating the axis. Until such evidence is obtained, the tumor–nerve–immune electrical axis should be regarded as a hypothesis-generating experimental program rather than a validated physiological circuit.

Full article
PrevPage 33 of 35 12…3132333435Next
Back to Top